icon-folder.gif   Conference Reports for NATAP  
 
  HIV Glasgow 2026
8-11 November
Back grey_arrow_rt.gif
 
 
 
Once-Weekly Oral Islatravir/Lenacapavir Versus Daily Standard of Care Across Participant Subgroups Through Week 48 in the Phase 3 ISLEND-2 Trial
 
 
  Glasgow 2026 Nov 8-11

1109261copy

1109262copy

1109263copy

1109264copy

1109265copy

1109266copy

1109267copy

1109268copy

1109269copy